These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22996646)

  • 1. Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method.
    Ashoor G; Syngelaki A; Wang E; Struble C; Oliphant A; Song K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2013 Jan; 41(1):21-5. PubMed ID: 22996646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IONA test for first-trimester detection of trisomies 21, 18 and 13.
    Poon LC; Dumidrascu-Diris D; Francisco C; Fantasia I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):184-7. PubMed ID: 26387684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy.
    Sarno L; Revello R; Hanson E; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):705-11. PubMed ID: 26970114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
    Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18.
    Ashoor G; Syngelaki A; Wagner M; Birdir C; Nicolaides KH
    Am J Obstet Gynecol; 2012 Apr; 206(4):322.e1-5. PubMed ID: 22464073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
    Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the neoBona test: a new paired-end massively parallel shotgun sequencing approach for cell-free DNA-based aneuploidy screening.
    Cirigliano V; Ordoñez E; Rueda L; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Apr; 49(4):460-464. PubMed ID: 27981672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA sequencing versus standard prenatal aneuploidy screening.
    Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
    N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MODELS OF CLINICAL IMPLEMENTATION OF CELL FREE FETAL DNA IN THE MATERNAL SERUM SCREENING TEST-ANALYSIS].
    Yankova M; Chaveeva P; Stratieva V
    Akush Ginekol (Sofiia); 2015; 54(7):15-21. PubMed ID: 27025103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of non-invasive prenatal testing by semiconductor sequencing in a genetic laboratory.
    Dheedene A; Sante T; De Smet M; Vanbellinghen JF; Grisart B; Vergult S; Janssens S; Menten B
    Prenat Diagn; 2016 Aug; 36(8):699-707. PubMed ID: 27176606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
    Gil MM; Quezada MS; Revello R; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Mar; 45(3):249-66. PubMed ID: 25639627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population.
    Nicolaides KH; Syngelaki A; Ashoor G; Birdir C; Touzet G
    Am J Obstet Gynecol; 2012 Nov; 207(5):374.e1-6. PubMed ID: 23107079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y.
    Nicolaides KH; Syngelaki A; Gil M; Atanasova V; Markova D
    Prenat Diagn; 2013 Jun; 33(6):575-9. PubMed ID: 23613152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive prenatal testing for fetal aneuploidy: charting the course from clinical validity to clinical utility.
    Hui L
    Ultrasound Obstet Gynecol; 2013 Jan; 41(1):2-6. PubMed ID: 23280734
    [No Abstract]   [Full Text] [Related]  

  • 16. [CLINICAL IMPLEMENTATION OF CELL-FREE DNA ANALYSIS IN MATERNAL BLOOD IN SCREENING FOR ANEUPLOIDIES IN SINGLETON PREGNANCIES].
    Chaveeva P; Yankova M; Stratieva V; Dimitrov I; Shterev A
    Akush Ginekol (Sofiia); 2016; 55(2):10-5. PubMed ID: 27509651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13.
    Papageorghiou AT; Khalil A; Forman M; Hulme R; Mazey R; Mousa HA; Johnstone ED; McKelvey A; Cohen KE; Risley M; Denman W; Kelly B
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):188-93. PubMed ID: 26493543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis.
    Iwarsson E; Jacobsson B; Dagerhamn J; Davidson T; Bernabé E; Heibert Arnlind M
    Acta Obstet Gynecol Scand; 2017 Jan; 96(1):7-18. PubMed ID: 27779757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks.
    Quezada MS; Gil MM; Francisco C; Oròsz G; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):36-41. PubMed ID: 25251385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort.
    Pergament E; Cuckle H; Zimmermann B; Banjevic M; Sigurjonsson S; Ryan A; Hall MP; Dodd M; Lacroute P; Stosic M; Chopra N; Hunkapiller N; Prosen DE; McAdoo S; Demko Z; Siddiqui A; Hill M; Rabinowitz M
    Obstet Gynecol; 2014 Aug; 124(2 Pt 1):210-218. PubMed ID: 25004354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.